Brexit is the wrong prescription, says European pharma industry
LONDON (Reuters) - Britain's departure from the European Union would threaten scientific research and jeopardize the 28-nation bloc's system of drug regulation, the European pharmaceutical industry said on Wednesday.
Aucun commentaire:
Enregistrer un commentaire